Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trialMiriam Santer, Alison Layton, Karen Thomas et al.|BMJ|2023Cited by 60
Digital intervention (Renewed) to support symptom management, wellbeing, and quality of life among cancer survivors in primary care: a randomised controlled trialPaul Little, Lucy Yardley, Katherine Bradbury et al.|British Journal of General Practice|2023Cited by 7
Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCTMiriam Santer, Alison Layton, Megan Lawrence et al.|Health Technology Assessment|2024Cited by 7
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trialSarah Pyne, Miriam Santer, Tracey Sach et al.|BMJ Open|2023Cited by 5
Social media recruitment enhances participant diversity in dermatology clinical trial: findings from the SAFA trialCherish Boxall, Miriam Santer, Susanne Renz et al.|Trials|2025Cited by 3